[Leish-l] FW: Leishmaniasis Pathology Network

[elfadil abass]

Dear Professor Paul Kaye,
Thank you for your email. That is really great! I fully agree with the idea and 
I would be very interested to be a collaborator in this network. I have started 
discussing the idea with my colleagues at Laboratory of Biomedical Research at 
Ahfad University in Sudan. 

 
Kind regards,
 
Elfadil Abass
PhD student, Institute for Microbiology, Philipps University Marburg- Germany
Member, Research Group at Laboratory for Biomedical Research- Omdurman, Sudan
 
 Elfadil Abass
________________________________________________________________________________
Referat 413-Africa
A/08/98948 Sudan
________________________________________________________________________________
Institute of Medical Microbiology and Hospital Hygiene
Philipps University Marburg
BMFZ / Hans-Meerwein Straße 2
D-35033 Marburg, Germany
________________________________________________________________________________




________________________________
From: jeffrey shaw <jayusp at hotmail.com>
To: Leish-L <leish-l at lineu.icb.usp.br>
Sent: Tue, August 9, 2011 4:41:13 PM
Subject: [Leish-l] FW: Leishmaniasis Pathology Network

 




________________________________
Date: Tue, 9 Aug 2011 11:58:52 +0100
From: paul.kaye at york.ac.uk

Subject: Leishmaniasis Pathology Network

 
Dear all,
Invitation to participate in a global pathology       network for       research 
and training in leishmaniasis (LeishPathNet)
You may recall the Dormy House meeting in 2008       and some of       the plans 
we put forward?  Over       the past       couple years, I have also spoken more 
to a few of you about one       idea that was       formulated at Dormy, namely 
of setting up a digital pathology       network. I have       also had numerous 
discussions with the major equipment       manufacturers to see if       any of 
them would be supportive of helping us to develop such an       initiative.  
There have       been two major       develoments recently.  First,       Carl 
Zeiss       is willing to work with us to set up an integrated global digital       
pathology       network (providing a significant financial and technical       
contribution) and       second, the Wellcome Trust is willing to review a 
pre-proposal to       fund the       initiative through their new Biomedical 
Resources Grant scheme 
(http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm)
       .
I have attached an outline of the project that       I had sent to       the 
Trust for their initial views, which I think is reasonably       
self-explanatory.  They appeared very       enthusiastic!  The main       
question now is whether enough of       you are still supportive? [ I will also 
be sending this email to       others, but please feel free to circulate ]

I think the         project will be         challenging, but success could have 
a real impact on the way we         conduct         business.  It should serve 
not only as a vehicle to enhance         research in         leishmaniasis, but 
the model would be equally applicable across         a broad range         of 
diseases and global challenges (with leishmaniasis setting         the pace).
If we wish to         proceed, the requirements         are that we submit a 
pre-proposal to the Trust by Oct 18th 2011.  This pre-proposal is short (4 
sections of 350 words) and         requires         letters of support from the 
community.   
If you are         supportive of the idea that         we try to take this 
forward (and there is plenty of scope for         later iteration         of the 
detail), I would be grateful if you could please provide         me with a         
letter of support by September           12th 2011, indicating whether you would 
like to be a network         partner if the bid         is successful.  You 
could         also be         supportive but not wish to become directly 
involved at this         stage, and such         letters are equally valuable. 
Your letter might also stress the         added value         that the network 
could provide, its importance for research and         training and/or         
for progressing the translational agenda.  It would also be an opportunity to 
indicate whether your         group (or         institute, if multiple groups) 
would be interested in bidding to         be one of the         initial 
‘designated laboratories’.  
If there is         sufficient support to         proceed and if subsequently 
the pre-proposal is successful (we         will know on 22nd Nov), then I will 
need a few volunteers to help finalise the         full proposal,         which 
will be due on Jan 26th 2012.  A funding decision will be made on May 26th 2012. 

Best wishes         and of course I am happy to         discuss any points 
further (though I will be out of the UK from         Aug 10 –Sept         12)
Paul
 



--  Professor Paul Kaye, Ph.D., FRCPath. Deputy Dean (Research), Hull York 
Medical School, and  Director, Centre for Immunology and Infection Department of 
Biology and Hull York Medical School University of York Wentworth Way York YO10 
5YW United Kingdom  Tel:  +44 (0)1904 328840 Fax:  +44 (0)1904 328844 Email: 
paul.kaye at york.ac.uk <mailto:paul.kaye at york.ac.uk>  Centre Administrator and PA: 
Elizabeth Greensted Tel:  01904 328845 Email: liz.greensted at york.ac.uk 
<mailto:liz.greensted at york.ac.uk>  Centre Email: cii at york.ac.uk 
<mailto:cii at york.ac.uk>  Centre website: http://www.york.ac.uk/cii  Times Higher 
Education University of the Year 2010  Email disclaimer: 
http://www.york.ac.uk/docs/disclaimer/email.htm  
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110815/103ad7b3/attachment.htm>